Quick Takeaways
- Nima Farzan has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $75,810.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Nima Farzan
- Location
- Lexington, MA
- Summary
- The estimated net worth of Nima Farzan is at least $75,810 dollars as of 06 Jun 2025. Nima Farzan is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $75.8K.
- Signature
- /s/ Keith Regnante, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Nima Farzan and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Keros Therapeutics, Inc. ($75,810).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Nima Farzan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Director | $75,810 | 04 Jun 2025 | ||
| KNTE | Kinnate Biopharma Inc. | CHIEF EXECUTIVE OFFICER, Director | $0 | 03 Apr 2024 |
Insider Transactions Reported by Nima Farzan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.